Xavier Avat - Net Worth and Insider Trading

Xavier Avat Net Worth

The estimated net worth of Xavier Avat is at least $0 dollars as of 2024-05-21. Xavier Avat is the Former CBO of Capricor Therapeutics Inc and owns about 0 shares of Capricor Therapeutics Inc (CAPR) stock worth over $0. Details can be seen in Xavier Avat's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Xavier Avat has not made any transactions after 2023-04-17 and currently still holds the listed stock(s).

Transaction Summary of Xavier Avat

To

Xavier Avat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Xavier Avat owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .

Click here to see the complete history of Xavier Avat’s form 4 insider trades.

Insider Ownership Summary of Xavier Avat

Ticker Comapny Transaction Date Type of Owner
CAPR Capricor Therapeutics Inc 2023-04-17 CHIEF BUSINESS OFFICER

Xavier Avat Latest Holdings Summary

Xavier Avat currently owns a total of 1 stock. Xavier Avat owns 0 shares of Capricor Therapeutics Inc (CAPR) as of April 17, 2023, with a value of $0.

Latest Holdings of Xavier Avat

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAPR Capricor Therapeutics Inc 2023-04-17 0 6.22 0

Holding Weightings of Xavier Avat


Xavier Avat Form 4 Trading Tracker

According to the SEC Form 4 filings, Xavier Avat has made a total of 3 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Capricor Therapeutics Inc is the sale of 14,772 shares on April 17, 2023, which brought Xavier Avat around $63,372.

Insider Trading History of Xavier Avat

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Xavier Avat Trading Performance

GuruFocus tracks the stock performance after each of Xavier Avat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xavier Avat is 63.99%. GuruFocus also compares Xavier Avat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xavier Avat within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Xavier Avat's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Xavier Avat

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.7
Relative Return to S&P 500(%) 19.89

Xavier Avat Ownership Network

Ownership Network List of Xavier Avat

No Data

Ownership Network Relation of Xavier Avat


Xavier Avat Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Xavier Avat is the CHIEF BUSINESS OFFICER of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include director & CHIEF EXECUTIVE OFFICER Linda Marban , EVP & GENERAL COUNSEL Karen Krasney , and CHIEF FINANCIAL OFFICER Anthony Bergmann .

Capricor Therapeutics Inc (CAPR) Insider Trades Summary

Over the past 18 months, Xavier Avat made 2 insider transaction in Capricor Therapeutics Inc (CAPR) with a net sale of 17,772. Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 10,000 shares made by Collier Earl M Jr , and a net purchase of 5,000 shares made by Paul Gisbert Auwaerter .

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,772 shares of Capricor Therapeutics Inc (CAPR) were sold and 22,993 shares were bought by its insiders, resulting in a net purchase of 5,221 shares.

Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Capricor Therapeutics Inc Insider Transactions

No Available Data

Xavier Avat Mailing Address

Above is the net worth, insider trading, and ownership report for Xavier Avat. You might contact Xavier Avat via mailing address: 10865 Road To The Cure, Suite 150, San Diego Ca 92121.

Discussions on Xavier Avat

No discussions yet.